Evidence now supports that cancer therapy using the ICS System cures breast and other cancers without harming the body unlike conventional cancer treatments
.ICS is a relatively new treatment for cancer treatment and although 10 year outcomes are not yet available, medical experts are supporting this effective, non-painful, non-harmful precise therapy as more than 7,000 patients have experienced HIFU. Adding to this, clinical tests and conclusions have been and will continue to be extremely encouraging.
Our technique is widely accepted and interest from many other countries is occurring due to the high success levels we have experienced in Asia. ICS HIFU can eradicate breast cancer, with zero harm to the body, no scarring, minimal hospital stay and an early return to everyday activities. ...and most important to many, many patients: months and months of breast reconstruction will not be necessary.
The following are a selection of industry reputable independent clinical tests and trials. - Click on a trial heading to read more
Bahy Ayoub, MD
AURO is recommending HIFU as a standard of care treatment for localized prostrate cancer
Supported by Expanding Physician Utilization of HIFU in Europe
Huang Disheng,
Ju Jiayin, Zhang Hong,
Shen Lan, Sun Kun,
He Guoqing
Duke University in Durham, North Carolina.